Cointime

O2 RegenTech

company

About

O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.

  • 1 - 10

Highlights

Total Funding Amount
$600K
Funding Rounds
1
Investors
2
Investments
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$600K
Industries
Clinical Trials,Commercial,Medical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

O2 RegenTech LLC is commercializing cost-effective, easy-to-use wound care solutions. Our proprietary, patented technology is used in our initial product offering, OXAID™, as an oxygenating, moist, and antimicrobial dressing to promote and accelerate chronic wound healing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$600K
O2 RegenTech has raised a total of $600K in funding over 2 rounds. Their latest funding was raised on Jan 26, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 26, 2017 Grant $600K 2 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
O2 RegenTech has made 1 investments. Their most recent investment was on Jun 14, 2021, when Convosight raised $9M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 14, 2021 Convosight
Series A $9M SaaS —

Investors

Number of Lead Investors
Number of Investors
—
2
O2 RegenTech is funded by 2 investors. National Institutes of Health and National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health — Grant
National Science Foundation — Grant
Cointime
Содержание
компания